3 Stocks Underperforming Today In The Real Estate Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 105 points (0.6%) at 16,554 as of Tuesday, April 22, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 2,226 issues advancing vs. 749 declining with 155 unchanged.

The Real Estate industry currently sits up 0.4% versus the S&P 500, which is up 0.6%. On the negative front, top decliners within the industry include CommonWealth REIT ( CWH), down 1.7%, Icahn ( IEP), down 1.3%, Macerich Company ( MAC), down 1.1%, Equity Residential ( EQR), down 0.9% and Regency Centers Corporation ( REG), down 0.8%. Top gainers within the industry include E-House China Holdings ( EJ), up 6.1%, Zillow ( Z), up 2.6%, KKR Financial Holdings ( KFN), up 2.6%, Howard Hughes ( HHC), up 2.0% and Realogy Holdings ( RLGY), up 1.7%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Ventas ( VTR) is one of the companies pushing the Real Estate industry lower today. As of noon trading, Ventas is down $0.66 (-1.0%) to $64.34 on light volume. Thus far, 602,625 shares of Ventas exchanged hands as compared to its average daily volume of 1.7 million shares. The stock has ranged in price between $63.86-$65.00 after having opened the day at $64.85 as compared to the previous trading day's close of $65.00.

Ventas, Inc. is a publicly owned real estate investment trust. The firm engages in investment, management, financing, and leasing of properties in the healthcare industry. It invests in the real estate markets of the United States and Canada. Ventas has a market cap of $19.2 billion and is part of the financial sector. Shares are up 13.5% year-to-date as of the close of trading on Monday. Currently there are 3 analysts that rate Ventas a buy, 3 analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Ventas as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, compelling growth in net income, reasonable valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Ventas Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Health Care REIT ( HCN) is down $0.68 (-1.1%) to $61.50 on light volume. Thus far, 593,059 shares of Health Care REIT exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $61.22-$62.18 after having opened the day at $62.04 as compared to the previous trading day's close of $62.18.

Health Care REIT, Inc. is an independent equity real estate investment trust. The firm engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets. It primarily invests in the real estate markets of the United States. Health Care REIT has a market cap of $18.0 billion and is part of the financial sector. Shares are up 16.1% year-to-date as of the close of trading on Monday. Currently there are 6 analysts that rate Health Care REIT a buy, 2 analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Health Care REIT as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full Health Care REIT Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, HCP ( HCP) is down $0.29 (-0.7%) to $40.53 on average volume. Thus far, 1.2 million shares of HCP exchanged hands as compared to its average daily volume of 3.2 million shares. The stock has ranged in price between $40.18-$40.85 after having opened the day at $40.85 as compared to the previous trading day's close of $40.82.

HCP, Inc. is an independent hybrid real estate investment trust. The fund invests in real estate markets of the United States. HCP has a market cap of $18.6 billion and is part of the financial sector. Shares are up 12.4% year-to-date as of the close of trading on Monday. Currently there are 3 analysts that rate HCP a buy, 2 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates HCP as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, compelling growth in net income, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full HCP Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the real estate industry could consider iShares Dow Jones US Real Estate ( IYR) while those bearish on the real estate industry could consider ProShares Short Real Estate Fund ( REK).

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing